Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law BPC 157: Experimental Peptide Creates Risk for Athletes FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger?